Disclosure Quest - Search SEC Filings

Name	Type of Offering	Accepted Date
Syros Pharmaceuticals, Inc. See All Filings	D	2022-09-21 17:07:26 UTC
Amount To Be Raised $129,843,346 Associated Brokers / Dealers Cowen and Company, LLC and Piper Sandler & Co. CIK Number 0001556263 Filed Document 0001556263-22-000001 Exclusions or Exemptions 506b Accepted Date 2022-09-21 17:07:26 UTC Type of Offering D Industry Biotechnology Principal Place of Business MASSACHUSETTS Revenue or Assets Decline to Disclose Type of Security Equity
Syros Pharmaceuticals, Inc. See All Filings	D	2020-12-17 16:21:41 UTC
Amount To Be Raised $121,609,375 Associated Brokers / Dealers N/A CIK Number 0001556263 Filed Document 0001556263-20-000001 Exclusions or Exemptions 506b Accepted Date 2020-12-17 16:21:41 UTC Type of Offering D Industry Biotechnology Principal Place of Business MASSACHUSETTS Revenue or Assets Decline to Disclose Type of Security Equity
Syros Pharmaceuticals, Inc. See All Filings	D/A	2018-02-09 08:52:15 UTC
Amount To Be Raised $11,380,018 Associated Brokers / Dealers N/A CIK Number 0001556263 Filed Document 0001556263-18-000002 Exclusions or Exemptions 506b Accepted Date 2018-02-09 08:52:15 UTC Type of Offering D/A Industry Biotechnology Principal Place of Business MASSACHUSETTS Revenue or Assets Decline to Disclose Type of Security Equity
Syros Pharmaceuticals, Inc. See All Filings	D	2018-01-17 16:13:48 UTC
Amount To Be Raised $9,999,995 Associated Brokers / Dealers N/A CIK Number 0001556263 Filed Document 0001556263-18-000001 Exclusions or Exemptions 506b Accepted Date 2018-01-17 16:13:48 UTC Type of Offering D Industry Biotechnology Principal Place of Business MASSACHUSETTS Revenue or Assets Decline to Disclose Type of Security Equity
Syros Pharmaceuticals, Inc. See All Filings	D	2014-10-24 00:00:00 UTC
Amount To Be Raised $53,149,996 Associated Brokers / Dealers N/A CIK Number 0001556263 Filed Document 0001556263-14-000001 Exclusions or Exemptions 506b Accepted Date 2014-10-24 00:00:00 UTC Type of Offering D Industry Biotechnology Principal Place of Business MASSACHUSETTS Revenue or Assets Decline to Disclose Type of Security Equity